Company Filing History:
Years Active: 2009-2015
Title: Michael Diegel: Innovator in Cancer and Infectious Disease Treatment
Introduction
Michael Diegel is a prominent inventor based in Covington, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for cancer and infectious diseases. With a total of 2 patents, Diegel's work is at the forefront of medical innovation.
Latest Patents
Diegel's latest patents focus on compositions employing alternative reading frame (ARF) polypeptides for the treatment of cancer and infectious disease. The first patent provides ARF polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise these polypeptides. These ARF polypeptides and their compositions are instrumental in addressing cancer and infectious diseases. The second patent also emphasizes the use of ARF polypeptides, detailing compositions and methods that utilize these polypeptides for therapeutic purposes.
Career Highlights
Michael Diegel is associated with Dendreon Corporation, a company known for its innovative approaches in cancer treatment. His work at Dendreon has allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
Diegel has collaborated with notable colleagues such as Thomas Graddis and Reiner Laus. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Michael Diegel's contributions to the field of biotechnology, particularly through his patents and collaborations, highlight his commitment to advancing treatments for cancer and infectious diseases. His work continues to inspire innovation in the medical community.